Style | Citing Format |
---|---|
MLA | Sedighiyan M, et al.. "The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms." Endocrine# Metabolic and Immune Disorders - Drug Targets, vol. 23, no. 5, 2023, pp. 711-720. |
APA | Sedighiyan M, Jafari E, Athar SS, Yekaninejad MS, Alvandi E, Abdolahi M, Djalali M (2023). The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms. Endocrine# Metabolic and Immune Disorders - Drug Targets, 23(5), 711-720. |
Chicago | Sedighiyan M, Jafari E, Athar SS, Yekaninejad MS, Alvandi E, Abdolahi M, Djalali M. "The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms." Endocrine# Metabolic and Immune Disorders - Drug Targets 23, no. 5 (2023): 711-720. |
Harvard | Sedighiyan M et al. (2023) 'The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms', Endocrine# Metabolic and Immune Disorders - Drug Targets, 23(5), pp. 711-720. |
Vancouver | Sedighiyan M, Jafari E, Athar SS, Yekaninejad MS, Alvandi E, Abdolahi M, et al.. The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms. Endocrine# Metabolic and Immune Disorders - Drug Targets. 2023;23(5):711-720. |
BibTex | @article{ author = {Sedighiyan M and Jafari E and Athar SS and Yekaninejad MS and Alvandi E and Abdolahi M and Djalali M}, title = {The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms}, journal = {Endocrine# Metabolic and Immune Disorders - Drug Targets}, volume = {23}, number = {5}, pages = {711-720}, year = {2023} } |
RIS | TY - JOUR AU - Sedighiyan M AU - Jafari E AU - Athar SS AU - Yekaninejad MS AU - Alvandi E AU - Abdolahi M AU - Djalali M TI - The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study From Gene Expression to Clinical Symptoms JO - Endocrine# Metabolic and Immune Disorders - Drug Targets VL - 23 IS - 5 SP - 711 EP - 720 PY - 2023 ER - |